Tempus AI, Inc.
🏢 View company profile →14Patents
14Active
14Granted
64Portfolio score
Filing activity: May 18, 2021 → Jun 22, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD1019606S1 | Speaker | General | 1 | Active |
| US12271832B2 | Artificial intelligence engine for directed hypothesis generation and ranking | Physics | 0 | Active |
| US12361542B2 | Systems and methods for deep orthogonal fusion for multimodal prognostic biomarker discovery | Physics | 0 | Active |
| US12203139B2 | Systems and methods for detecting multi-molecule biomarkers | Physics | 0 | Active |
| US12119103B2 | GANs for latent space visualizations | Physics | 0 | Active |
| US12165753B2 | Systems and methods for interrogating clinical documents for characteristic data | Physics | 0 | Active |
| US12062372B2 | Collaborative artificial intelligence method and system | Physics | 0 | Active |
| US12365943B2 | Systems and methods for next generation sequencing uniform probe design | Chemistry; Metallurgy | 0 | Active |
| US12165236B2 | Predicting total nucleic acid yield and dissection boundaries for histology slides | Physics | 0 | Active |
| US12190884B2 | Collaborative artificial intelligence method and system | Physics | 0 | Active |
| US12129519B2 | TCR/BCR profiling using enrichment with pools of capture probes | Physics | 0 | Active |
| US12217429B2 | 3D radiomic platform for imaging biomarker development | Physics | 0 | Active |
| US12112839B2 | Data based cancer research and treatment systems and methods | Physics | 0 | Active |
| US12412665B2 | Methods for evaluating the effect of the start date for cancer treatment with a cancer medication using propensity scoring | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.